Reducing the cost of post-exposure rabies prophylaxis: Efficacy of 0.1 ml PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals

Vaccine

Volumn 23, Issue 14, 2005, Pages 1709-1714

  Quiambao, Beatriz P ^a   Dimaano, Efren M ^b   Ambas, Cristina ^a   Davis, Rolan ^c   Banzhoff, Angelika ^d   Malerczyk, Claudius ^d  

^a Department of Health   (Philippines)

^b San Lazaro Hospital   (Philippines)

^c KANSAS STATE UNIVERSITY   (United States)

^d Chiron Vaccines   (Germany)

Author keywords

Intradermal; PCECV; Rabies

Indexed keywords

AMPHOTERICIN B; NEOMYCIN; RABIES VACCINE; TETRACYCLINE;

ADOLESCENT; ADULT; ANIMAL MODEL; ARTICLE; BIOLOGICAL MONITORING; BITE; CONTROLLED STUDY; COST; DEATH; DRUG TOLERABILITY; EMBRYO CELL; FEVER; HEADACHE; HUMAN; HYPERSENSITIVITY; MAJOR CLINICAL STUDY; NONHUMAN; PHILIPPINES; PRIORITY JOURNAL; PROPHYLAXIS; RABIES; REDUCTION; SIDE EFFECT;

EID: 13444278883     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.09.027     Document Type: Article

References (22)

1. H. Wilde, D.J. Briggs, F.X. Meslin, T. Hemachudha, and V. Sitprija Rabies update for travel medicine advisors Clin Infect Dis 37 2003 96 100
2. S. Parviz, S. Luby, and H. Wilde Postexposure treatment of rabies in Pakistan Clin Infect Dis 27 1998 751 756
3. Rabies control in Asia Proceedings of the Fourth International Symposium 5-9 March 2001 Hanoi, Vietnam 2004 248
4. Miranda ME. Rabies in the Philippines: Control and Future Prospects, Public Health Forum 2000. University of the Philippines, College of Public Health. Annex II.
5. WHO Expert Committee on Rabies. WHO Tech Rep 824. 1992: pp. 1-84.
6. S. Chutivongse, H. Wilde, C. Supich, G.M. Baer, and D.B. Fishbein Postexposure prophylaxis for rabies with antiserum and intradermal vaccination Lancet 335 1990 896 898
7. D.J. Briggs, A. Banzhoff, U. Nicolay, S. Sirikwin, B. Dumavibhat, and S. Tongswas Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine Bull World Health Organ 78 2000 693 698
8. T. Kamoltham, J. Singhsa, U. Promsaranee, P. Sonthon, P. Mathean, and W. Thinyounyong Elimination of human rabies in a canine endemic province in Thailand: five-year programme Bull World Health Organ 81 2003 375
9. WHO recommendations on rabies post-exposure treatment and correct technique of intradermal immunization against rabies. WHO/EMC/ZOO/96.6. Geneva: WHO; 1997
10. U. Charanasri, V. Meesomboon, D. Kingnate, P. Samuthananon, and W. Chaeychomsri Intradermal simulated rabies postexposure prophylaxis using purified chick embryo rabies vaccine J Med Assoc Thai 75 1992 639 643
11. S. Tanterdtham, P. Chaiprasithikul, K. Yuthavong, and C. Wasi Follow-up of protective antibody level after post-exposure vaccination with purified tissue culture rabies vaccine (PCEC) small doses intradermally J Med Assoc Thai 74 1991 498 501
12. P. Suntharasamai, P. Chaiprasithikul, C. Wasi, W. Supanaranond, P. Auewarakul, and P. Chanthavanich A simplified and economical intradermal regimen of purified chick embryo cell rabies vaccine for postexposure prophylaxis Vaccine 12 1994 508 512
13. C.V. Trimarchi, and J.G. Debbie The fluorescent antibody in rabies G.M. Baer The natural history of rabies 1991 CDC Press Boca Raton p. 219-33
14. P. Sureau, P. Ravisse, and P.E. Rollin Rabies diagnosis by animal inoculation, identification of negri bodies, or ELISA G.M. Baer The Natural History of Rabies 1991 CRC Press Boca Raton, FL p. 204-17
15. J.S. Smith, P.A. Yager, and G.M. Baer A rapid tissue culture test for determining rabies-neutralizing antibody F.X. Meslin M.M. Kaplan H. Koprowski Laboratory Techniques in Rabies 4th ed. 1996 WHO Geneva, Switzerland p. 354-57
16. C.E. Rupprecht, C.A. Hanlon, and T. Hemachudha Rabies re-examined Lancet Infect Dis 2 2002 327 343
17. O. Thraenhart, and D.J. Briggs Rabies virus neutralization testing: does the variant of challenge virus used in the test influence the measurement of neutralizing antibody? Proceedings of the XIII International Meeting on Research Advances and Rabies Control in the Americas Oaxaca 2002
18. K. Habel Laboratory data supporting the clinical trial of antirabies serum in persons bitten by a rabid wolf Bull World Health Organ 13 1955 773 779
19. S.A. Plotkin Rabies Clin Infect Dis 30 2000 4 12
20. D.L. Lodmell, and L.C. Ewalt Rabies cell culture vaccines reconstituted and stored at 4 degrees C for 1 year prior to use protect mice against rabies virus Vaccine 22 2004 3237 3239
21. P. Khawplod, H. Wilde, T. Tantawichien, S. Limusanno, T. Tantawichien, and C. Mitmoonpitak Potency, sterility and immunogenicity of rabies tissue culture vaccine after reconstitution and refrigerated storage for 1 week Vaccine 20 2002 2240 2242
22. T. Kamoltham, P. Khawplod, and H. Wilde Rabies intradermal post-exposure vaccination of humans using reconstituted and stored vaccine Vaccine 20 2002 3272 3276